ALPHA TEKNOVA, INC. Operating Income
ALPHA TEKNOVA, INC. (TKNO) reported Operating Income of -$2.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- ALPHA TEKNOVA, INC. operating income (loss) for the quarter ending 2026-06-30 was -$2.89M.
- ALPHA TEKNOVA, INC. operating income (loss) for the quarter ending 2026-03-31 was -$4.30M.
- ALPHA TEKNOVA, INC. operating income (loss) for the quarter ending 2025-12-31 was -$4.61M.
- ALPHA TEKNOVA, INC. operating income (loss) for the quarter ending 2025-09-30 was -$4.02M.
- ALPHA TEKNOVA, INC. operating income (loss) for fiscal 2025 was -$16.98M.
- ALPHA TEKNOVA, INC. operating income (loss) for fiscal 2024 was -$26.15M.
- ALPHA TEKNOVA, INC. operating income (loss) for fiscal 2023 was -$35.56M.
- ALPHA TEKNOVA, INC. operating income (loss) for fiscal 2022 was -$49.66M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.89M 10-Q · filed 2026-08-06 | -$7.19M 10-Q · filed 2026-08-06 | -$11.80M derived: sum of 3 quarters · filed 2026-08-06 | -$15.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.30M 10-Q · filed 2026-05-07 | -$8.91M derived: sum of 2 quarters · filed 2026-05-07 | -$12.92M derived: sum of 3 quarters · filed 2026-05-07 | -$16.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$8.63M derived: sum of 2 quarters · filed 2026-03-02 | -$12.01M derived: sum of 3 quarters · filed 2026-08-06 | -$16.98M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$4.02M 10-Q · filed 2025-11-07 | -$7.40M derived: sum of 2 quarters · filed 2026-08-06 | -$12.37M 10-Q · filed 2025-11-07 | -$18.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.39M 10-Q · filed 2026-08-06 | -$8.35M 10-Q · filed 2026-08-06 | -$13.98M derived: sum of 3 quarters · filed 2026-08-06 | -$21.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.96M 10-Q · filed 2026-05-07 | -$10.59M derived: sum of 2 quarters · filed 2026-05-07 | -$18.02M derived: sum of 3 quarters · filed 2026-05-07 | -$23.12M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$13.06M derived: sum of 2 quarters · filed 2026-03-02 | -$18.16M derived: sum of 3 quarters · filed 2026-03-02 | -$26.15M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$7.43M 10-Q · filed 2025-11-07 | -$12.53M derived: sum of 2 quarters · filed 2025-11-07 | -$20.52M 10-Q · filed 2025-11-07 | -$31.38M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$5.10M 10-Q · filed 2025-08-08 | -$13.09M 10-Q · filed 2025-08-08 | -$23.94M derived: sum of 3 quarters · filed 2025-08-08 | -$32.71M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$7.99M 10-Q · filed 2025-05-09 | -$18.84M derived: sum of 2 quarters · filed 2025-05-09 | -$27.61M derived: sum of 3 quarters · filed 2025-05-09 | -$34.60M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$10.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$19.62M derived: sum of 2 quarters · filed 2025-03-07 | -$26.62M derived: sum of 3 quarters · filed 2025-03-07 | -$35.56M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$8.76M 10-Q · filed 2024-11-08 | -$15.76M derived: sum of 2 quarters · filed 2024-11-08 | -$24.70M 10-Q · filed 2024-11-08 | -$38.94M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$7.00M 10-Q · filed 2024-08-13 | -$15.94M 10-Q · filed 2024-08-13 | -$30.18M derived: sum of 3 quarters · filed 2024-08-13 | -$53.13M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$8.95M 10-Q · filed 2024-05-13 | -$23.18M derived: sum of 2 quarters · filed 2024-05-13 | -$46.14M derived: sum of 3 quarters · filed 2024-05-13 | -$52.76M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$37.19M derived: sum of 2 quarters · filed 2024-03-27 | -$43.82M derived: sum of 3 quarters · filed 2024-03-27 | -$49.66M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$22.95M 10-Q · filed 2023-11-13 | -$29.58M derived: sum of 2 quarters · filed 2023-11-13 | -$35.42M 10-Q · filed 2023-11-13 | -$40.19M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$6.63M 10-Q · filed 2023-08-11 | -$12.47M 10-Q · filed 2023-08-11 | -$17.24M derived: sum of 3 quarters · filed 2023-08-11 | -$21.12M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$5.84M 10-Q · filed 2023-05-11 | -$10.61M derived: sum of 2 quarters · filed 2023-05-11 | -$14.50M derived: sum of 3 quarters · filed 2023-05-11 | -$17.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$8.65M derived: sum of 2 quarters · filed 2023-03-30 | -$11.18M derived: sum of 3 quarters · filed 2023-03-30 | -$12.01M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.89M 10-Q · filed 2022-11-14 | -$6.41M derived: sum of 2 quarters · filed 2022-11-14 | -$7.24M 10-Q · filed 2022-11-14 | -$6.45M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$2.53M 10-Q · filed 2022-08-11 | -$3.35M 10-Q · filed 2022-08-11 | -$2.56M derived: sum of 3 quarters · filed 2022-08-11 | -$407.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$828.00K 10-Q · filed 2022-05-12 | -$33.00K derived: sum of 2 quarters · filed 2022-05-12 | $2.12M derived: sum of 3 quarters · filed 2022-05-12 | $2.82M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $2.95M derived: sum of 2 quarters · filed 2022-03-18 | $3.65M derived: sum of 3 quarters · filed 2022-03-18 | $4.66M 10-K · filed 2022-03-18 |
| 2020-09-30 | $2.15M 10-Q · filed 2021-11-12 | $2.86M derived: sum of 2 quarters · filed 2021-11-12 | $3.87M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $704.00K 10-Q · filed 2021-08-13 | $1.72M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |